Clover is an associate in the Emerging Companies and M&A team in London. She specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.
Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices
